再鼎医药在JPM大会上公布盈利时间表,创新药商业化受关注

第一财经
16 Jan

在全球最大的医疗投资大会摩根大通医疗健康大会(JPM大会)上,中国生物医药公司正在吸引越来越多国际投资人的关注,包括再鼎医药、百济神州在内的中国生物医药公司向投资人透露了盈利时间表。  截至1月16日收盘,再鼎医药(9699.HK)、百济神州(6160.HK)港股股价均大涨超过4%。  当地时间1月15日,再鼎医药在JPM大会上宣布,公司将在2025年底前实现盈利,预计到2028年将实现20亿美元...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10